Global HPV Testing Market Growth (Status and Outlook) 2023-2029

Global HPV Testing Market Growth (Status and Outlook) 2023-2029

The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing, co-testing, HPV primary testing.

LPI (LP Information)' newest research report, the “HPV Testing Industry Forecast” looks at past sales and reviews total world HPV Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected HPV Testing sales for 2023 through 2029. With HPV Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HPV Testing industry.

This Insight Report provides a comprehensive analysis of the global HPV Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on HPV Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global HPV Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HPV Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HPV Testing.

The global HPV Testing market size is projected to grow from US$ 784.6 million in 2022 to US$ 1398.7 million in 2029; it is expected to grow at a CAGR of 8.6% from 2023 to 2029.

Global HPV Testing key players include Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD, etc. Global top five players hold a share about 80%.

North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent.

In terms of product, Co-testing is the largest segment, with a share about 55%. And in terms of application, the largest application is Cervical Cancer Screening, followed by Vaginal Cancer Screening, etc.

This report presents a comprehensive overview, market shares, and growth opportunities of HPV Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

HPV Testing

Follow-up HPV Testing

Co-testing

Segmentation by application

Cervical Cancer Screening

Vaginal Cancer Screening

Other

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Qiagen

Roche Diagnostics

Hologic

Abbott Laboratories

BD

Seegene, Inc.

Please note: The report will take approximately 2 business days to prepare and deliver.